Literature DB >> 33742148

AI-based smartphone apps for risk assessment of skin cancer need more evaluation and better regulation.

Rubeta N Matin1, Jacqueline Dinnes2,3.   

Abstract

Smartphone applications ("apps") with artificial intelligence (AI) algorithms are increasingly used in healthcare. Widespread adoption of these apps must be supported by a robust evidence-base and app manufacturers' claims appropriately regulated. Current CE marking assessment processes inadequately protect the public against the risks created by using smartphone diagnostic apps.

Entities:  

Mesh：

Year:  2021        PMID： 33742148      PMCID： PMC8144419          DOI： 10.1038/s41416-021-01302-3

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  2 in total

1.  Accuracy of commercially available smartphone applications for the detection of melanoma.

Authors:  M D Sun; J Kentley; P Mehta; S Dusza; A C Halpern; V Rotemberg
Journal:  Br J Dermatol       Date:  2022-01-20       Impact factor: 11.113

2.  Over-Detection of Melanoma-Suspect Lesions by a CE-Certified Smartphone App: Performance in Comparison to Dermatologists, 2D and 3D Convolutional Neural Networks in a Prospective Data Set of 1204 Pigmented Skin Lesions Involving Patients' Perception.

Authors:  Anna Sophie Jahn; Alexander Andreas Navarini; Sara Elisa Cerminara; Lisa Kostner; Stephanie Marie Huber; Michael Kunz; Julia-Tatjana Maul; Reinhard Dummer; Seraina Sommer; Anja Dominique Neuner; Mitchell Paul Levesque; Phil Fang Cheng; Lara Valeska Maul
Journal:  Cancers (Basel)       Date:  2022-08-07       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.